The largest database of trusted experimental protocols

Bomcc

Manufactured by Molecular Devices
Sourced in United States

BOMCC is a fluorescent dye compound that can be used as a substrate for enzyme activity assays. It emits a measurable fluorescent signal upon enzymatic cleavage, allowing for the quantification of enzyme activity. The core function of BOMCC is to serve as a fluorogenic reporter molecule in biochemical and cell-based assays.

Automatically generated - may contain errors

5 protocols using bomcc

1

Evaluation of CYP Enzyme Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The activity of CYP3A4, CYP3A5, or CYP2C9 in the presence of WT or mutant POR was tested using the fluorogenic substrate BOMCC (Invitrogen Corp, Carlsbad, CA, USA). The purified CYP3A4, CYP3A5, or CYP2C9 (CYPEX, Dundee, Scotland, UK) were used to test the activities of the POR variants using 20 μM BOMCC as substrate. In vitro CYP3A5 assays were performed using a reconstituted liposome system consisting of pure WT/mutant POR, CYP3A5/CYP2C9, and cytochrome b5 at a ratio of 5:1:1. The final assay mixture consisted of 20 µM DLPC (1,2-Dilauroyl-snglycero-3-phosphocholine)/DLPGV (1,2-Dilauroyl-sn-glycero-3-phosphoglycerol) and proteins (100 nM POR: 20 nM CYP2C9: 20 nM b5), 3 mM MgCl2, 20 μM BOMCC in 50 mM Tris-HCl buffer pH 7.4 and the reaction volume was 100 µL. The CYP3A5 reaction was started by the addition of NADPH to the 1mM final concentration, and fluorescence was measured on a Spectramax M2e plate reader (Molecular Devices, Sunnyvale, CA, USA) at an excitation wavelength of 415 nm and an emission wavelength of 460 nm for BOMCC [21 (link),31 (link),33 (link)].
+ Open protocol
+ Expand
2

CYP2C9 Activity Assay with POR Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
The activity of CYP2C9 promoted by WT or mutant POR was tested using the fluorogenic substrate BOMCC (Invitrogen Corp, Carlsbad, CA, USA). The purified CYP2C9 (CYPEX, Dundee, Scotland, United Kingdom) was used to test the activities of the POR variants using 20 µM BOMCC as substrate. In vitro CYP2C9 assays were performed using a reconstituted liposome system consisting of WT/mutant POR, CYP2C9, and cytochrome b5 at a ratio of 5:1:1. The final assay mixture consisted of 5 µg DLPC (1,2-Dilauroyl-sn-glycero-3-phosphocholine) and proteins (1 µM POR: 200 nM CYP2C9: 200 nM b5), 3 mM MgCl2, 20 µM BOMCC in 100 mM Tris-HCl buffer PH 7.4, and the reaction volume was 100 µL. The P450 reaction was started by addition of NADPH to a final concentration of 1 mM, and fluorescence was measured on a Spectramax M2e plate reader (Molecular Devices, Sunnyvale, CA, USA) at an excitation wavelength of 415 nm and an emission wavelength of 460 nm for BOMCC.
+ Open protocol
+ Expand
3

CYP3A5 Activity Assay with POR Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
The activity of CYP3A5 promoted by WT or mutant POR was tested using the fluorogenic substrate BOMCC (Invitrogen Corp, Carlsbad, CA, USA). The purified CYP3A5 (CYPEX, Dundee, Scotland, UK) was used to test the activities of the POR variants using 20 µM BOMCC as substrate. In vitro CYP3A5 assays were performed using a reconstituted liposome system consisting of WT/mutant POR, CYP3A5 and cytochrome b5 at a ratio of 5:1:1. The final assay mixture consisted of 5 µg DLPC (1,2-Dilauroyl-sn-glycero-3-phosphocholine) and proteins (1 µM POR: 200 nM CYP2C9: 200 nM b5), 3 mM MgCl2, 20 µM BOMCC in 100 mM Tris-HCl buffer PH 7.4, and the reaction volume was 100 µL. The CYP3A5 reaction was started by addition of NADPH to 1 mM final concentration, and fluorescence was measured on a Spectramax M2e plate reader (Molecular Devices, Sunnyvale, CA, USA) at an excitation wavelength of 415 nm and an emission wavelength of 460 nm for BOMCC.
+ Open protocol
+ Expand
4

CYP2C9 Activity Assay with POR Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
The activity of CYP2C9 promoted by WT or mutant POR was tested using the fluorogenic substrate BOMCC (Invitrogen Corp, Carlsbad, CA, United States). The purified CYP2C9 (CYPEX, Dundee, Scotland, United Kingdom) was used to test the activities of the POR variants using 20 µM BOMCC as substrate. In vitro CYP2C9 assays were performed using a reconstituted liposome system consisting of WT/mutant POR, CYP2C9 and cytochrome b5 at a ratio of 5:1:1. The final assay mixture consisted of 5 µg DLPC (1,2-Dilauroyl-sn-glycero-3-phosphocholine) and proteins (1 µM POR: 200 nM CYP2C9: 200 nM b5), 3 mM MgCl2, 20 µM BOMCC in 100 mM Tris-HCl buffer pH 7.4 and the reaction volume was 100 µL. The P450 reaction was started by addition of NADPH to a final concentration of 1 mM, and fluorescence was measured on a Spectramax M2e plate reader (Molecular Devices, Sunnyvale, CA, United States) at an excitation wavelength of 415 nm and an emission wavelength of 460 nm for BOMCC.
+ Open protocol
+ Expand
5

Evaluating CYP3A5 Activity with POR Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
The activity of CYP3A5 promoted by WT or mutant POR was tested using the fluorogenic substrate BOMCC (Invitrogen Corp, Carlsbad, CA, United States). The purified CYP3A5 (CYPEX, Dundee, Scotland, United Kingdom) was used to test the activities of the POR variants using 20 µM BOMCC as substrate. In vitro CYP3A5 assays were performed using a reconstituted liposome system consisting of WT/mutant POR, CYP3A5 and cytochrome b5 at a ratio of 5:1:1. The final assay mixture consisted of 5 µg DLPC (1,2-Dilauroyl-sn-glycero-3-phosphocholine) and proteins (1 µM POR: 200 nM CYP2C9: 200 nM b5), 3 mM MgCl2, 20 µM BOMCC in 100 mM Tris-HCl buffer pH 7.4 and the reaction volume was 100 µL. The CYP3A5 reaction was started by addition of NADPH to 1 mM final concentration, and fluorescence was measured on a Spectramax M2e plate reader (Molecular Devices, Sunnyvale, CA, United States) at an excitation wavelength of 415 nm and an emission wavelength of 460 nm for BOMCC.
Protein structure analysis of POR variants: Three-dimensional structural models of POR (NCBI# NP_000932) proteins were obtained from the protein structure database (www.rcsb.org). We used the structures of the human POR (PDB # 3QE2) to analyze the
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!